Drugs / Human protein C concentrate
Human protein C concentrate
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT01411670 | Jan 2011 → Feb 2015 | infectious disease with sepsis | University of Roma La Sapienza | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Human protein C concentrate | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01411670 ↗ |
| Modality | Protein / enzyme biologic | “Continuous infusion of human protein C concentrate at the dose of 3 UI/Kg/Hr to reach a protein C plasma activity of 70-120%” NCT01411670 ↗ |